A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
for Alzheimer Disease
52 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 55+
Code: NCT07602582·Phase 3·Recruiting·Listed May 2026
Vector Clinical Trials
Clinical research site in Las Vegas, Nevada
Part of Vector Clinical Trials
As of July 2026, 15 paid clinical trials are recruiting at Vector Clinical Trials in Las Vegas, Nevada. Active studies at this site cover conditions such as Alzheimer Disease, Dementia and Plaque, Amyloid. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Vector Clinical Trials (15)
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
for Depressive Disorder, Major
32 locations incl. Moorpark
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07412756·Phase 3·Recruiting·Listed Feb 2026
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
for Elevated Lp(a)
127 locations incl. Gilbert
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07157774·Phase 3·Recruiting·Listed Sep 2025
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
for Obesity
26 locations incl. Gilbert
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07215559·Phase 2·Recruiting·Listed Oct 2025
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for Diabetes Mellitus, Type 2
211 locations incl. Anniston
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07064473·Phase 3·Recruiting·Listed Jul 2025
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
for Atherosclerotic Cardiovascular Disease
138 locations incl. Daphne
Sponsor: Amgen
Sex: All·Age: 45 - 99
Code: NCT07037433·Phase 3·Recruiting·Listed Jun 2025
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for Diabetes Mellitus, Type 2
123 locations incl. Chandler
Sponsor: Cleerly, Inc.
Sex: All·Age: 55+·Accepts healthy volunteers
Code: NCT06112418·Recruiting·Listed Nov 2023
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
for Crohn's Disease
56 locations incl. Dothan
Sponsor: AbbVie
Sex: All·Age: 18 - 75
Code: NCT06548542·Phase 2·Recruiting·Listed Aug 2024
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
for Major Depressive Disorder
23 locations incl. Birmingham
Sponsor: Syndeio Biosciences, Inc
Sex: All·Age: 18 - 64
Code: NCT06547489·Phase 2·Recruiting·Listed Aug 2024
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
for Irritability Associated With Autism Spectrum Disorder
27 locations incl. Dothan
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All·Age: 5 - 17
Code: NCT06690398·Phase 3·Recruiting·Listed Nov 2024
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
for Atherosclerosis
17 locations incl. La Jolla
Sponsor: Eli Lilly and Company
Sex: All·Age: 45 - 80
Code: NCT07613294·Phase 3·Recruiting·Listed May 29, 2026
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
for Colitis, Ulcerative
15 locations incl. Scottsdale
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 80
Code: NCT07483073·Phase 2·Recruiting·Listed Mar 2026
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
for Crohn Disease
15 locations incl. Scottsdale
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 80
Code: NCT07483099·Phase 2·Recruiting·Listed Mar 2026
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
for Smoking
15 locations incl. Rogers
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07223840·Phase 2·Recruiting·Listed Nov 2025
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
for Crohn's Disease
19 locations incl. Sun City
Sponsor: Sanofi
Sex: All·Age: 18 - 75
Code: NCT06637631·Phase 2·Recruiting·Listed Oct 2024
More research sites in Las Vegas
- OptumCare Cancer Care at Charleston (48 trials)
- OptumCare Cancer Care at Fort Apache (46 trials)
- Comprehensive Cancer Centers of Nevada (43 trials)
- Alliance for Childhood Diseases/Cure 4 the Kids Foundation (43 trials)
- Summerlin Hospital Medical Center (39 trials)
- University Medical Center of Southern Nevada (32 trials)
- Sunrise Hospital and Medical Center (27 trials)
- Comprehensive Cancer Centers of Nevada - Central Valley (25 trials)
- Comprehensive Cancer Centers of Nevada - Northwest (23 trials)
- Comprehensive Cancer Centers of Nevada - Town Center (23 trials)
Explore more
Paid clinical trials in Las Vegas, NV · Nevada clinical trials